Gene expression profiling of breast fibroadenomas

ABSTRACT: Fibroadenomas are the most common benign breast tumors in women under 30. Unlike their malignant counterparts, relatively molecular profiling has been done on fibroadenomas. Here we performed gene expression profiling on ten fibroadenomas in order to better characterize these tumors. Through targeted amplicon sequencing, we have found that six of these tumors have MED12 mutations. Here, we show that the MED12 mutations, among others, are associated with activated estrogen signaling, as well as increased invasiveness through upregulation of ECM remodelling genes. Microarray gene expression profiling was performed on 10 breast fibroadenomas and a combination of unsupervised and supervised clustering was performed to determine any differentially activated pathways between samples with mutated

ORGANISM(S): Homo sapiens

SUBMITTER: Weng Khong Lim 

PROVIDER: E-GEOD-55594 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress